Myriad, U. lose ruling over breast cancer-gene patents
Posted by admin on 3 April, 2010
No comments yet
This item was filled under [ Breast Cancer Treatment ]
Myriad, U. lose ruling over breast cancer-gene patents
A federal court ruling invalidating patents on human genes held by Myriad Genetics Inc. should have little effect on the Utah company’s operations, a top official said Monday.
Read more on The Salt Lake Tribune
Related posts
- Hormone Treatment Breast Cancer - A Breast Cancer Story
- Breast Cancer: Died After Extensive & Costly Medical Treatment
- Junk food during pregnancy 'raises breast cancer risk for kids, grandkids'
- Breast Cancer Treatment Information Lecture part 3
- OBESITY & BREAST CANCER: Overweight Women have Poorer Prognosis
- Does Breast Cancer Awareness Saves Lives?
- Inflammatory Breast Cancer?
- Follow up after breast cancer Treatment. Rupa Subramanian, MD
- There is Life After Breast Cancer
- Reducing the Risk of Breast Cancer
Popularity: 18 views